A randomized, double-blind, parallel pharmacokinetic study comparing the trastuzumab biosimilar candidate, AryoTrust®, and reference trastuzumab in healthy subjects.
Saved in:
| Title: | A randomized, double-blind, parallel pharmacokinetic study comparing the trastuzumab biosimilar candidate, AryoTrust®, and reference trastuzumab in healthy subjects. |
|---|---|
| Authors: | Farmahini Farahani M; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences , Karaj, Iran.; Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences , Karaj, Iran., Maghzi P; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences , Karaj, Iran.; Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences , Karaj, Iran., Jafari Aryan N; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences , Karaj, Iran.; Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences , Karaj, Iran., Payandemehr B; Experimental Medicine Research Center, Tehran University of Medical Sciences , Tehran, Iran., Soni M; Cliantha Research Limited, Cliantha Research Limited , Ahmedabad, Gujarat, India., Azhdarzadeh M; Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences , Karaj, Iran.; Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences , Tehran, Iran. |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2020 Dec; Vol. 29 (12), pp. 1443-1450. Date of Electronic Publication: 2020 Oct 12. |
| Publication Type: | Comparative Study; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33016783 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A randomized, double-blind, parallel pharmacokinetic study comparing the trastuzumab biosimilar candidate, AryoTrust®, and reference trastuzumab in healthy subjects. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Farmahini+Farahani+M%22">Farmahini Farahani M</searchLink>; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences , Karaj, Iran.; Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences , Karaj, Iran.<br /><searchLink fieldCode="AU" term="%22Maghzi+P%22">Maghzi P</searchLink>; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences , Karaj, Iran.; Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences , Karaj, Iran.<br /><searchLink fieldCode="AU" term="%22Jafari+Aryan+N%22">Jafari Aryan N</searchLink>; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences , Karaj, Iran.; Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences , Karaj, Iran.<br /><searchLink fieldCode="AU" term="%22Payandemehr+B%22">Payandemehr B</searchLink>; Experimental Medicine Research Center, Tehran University of Medical Sciences , Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Soni+M%22">Soni M</searchLink>; Cliantha Research Limited, Cliantha Research Limited , Ahmedabad, Gujarat, India.<br /><searchLink fieldCode="AU" term="%22Azhdarzadeh+M%22">Azhdarzadeh M</searchLink>; Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences , Karaj, Iran.; Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences , Tehran, Iran. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229434197%22">Expert opinion on investigational drugs</searchLink> [Expert Opin Investig Drugs] 2020 Dec; Vol. 29 (12), pp. 1443-1450. <i>Date of Electronic Publication: </i>2020 Oct 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9434197 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213543784%22">13543784 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Investig Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33016783 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/13543784.2020.1831470 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1443 Titles: – TitleFull: A randomized, double-blind, parallel pharmacokinetic study comparing the trastuzumab biosimilar candidate, AryoTrust®, and reference trastuzumab in healthy subjects. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Farmahini Farahani M – PersonEntity: Name: NameFull: Maghzi P – PersonEntity: Name: NameFull: Jafari Aryan N – PersonEntity: Name: NameFull: Payandemehr B – PersonEntity: Name: NameFull: Soni M – PersonEntity: Name: NameFull: Azhdarzadeh M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2020 Dec Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1744-7658 Numbering: – Type: volume Value: 29 – Type: issue Value: 12 Titles: – TitleFull: Expert opinion on investigational drugs Type: main |
| ResultId | 1 |
